Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

PARP1 hinders histone H2B occupancy at the NFATc1 promoter to restrain osteoclast differentiation.

Wang C, Xiao J, Nowak K, Gunasekera K, Alippe Y, Speckman S, Yang T, Kress D, Abu-Amer Y, Hottiger MO, Mbalaviele G.

J Bone Miner Res. 2019 Dec 2. doi: 10.1002/jbmr.3927. [Epub ahead of print]

PMID:
31793068
2.

Erratum: Hopp, A.K., et al. Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation. Cells 2019, 8, 890.

Hopp AK, Grüter P, Hottiger MO.

Cells. 2019 Oct 31;8(11). pii: E1371. doi: 10.3390/cells8111371.

3.

Regulation of Glucose Metabolism by NAD+ and ADP-Ribosylation.

Hopp AK, Grüter P, Hottiger MO.

Cells. 2019 Aug 13;8(8). pii: E890. doi: 10.3390/cells8080890. Review. Erratum in: Cells. 2019 Oct 31;8(11):.

4.

A Bacterial Effector Reveals the V-ATPase-ATG16L1 Axis that Initiates Xenophagy.

Xu Y, Zhou P, Cheng S, Lu Q, Nowak K, Hopp AK, Li L, Shi X, Zhou Z, Gao W, Li D, He H, Liu X, Ding J, Hottiger MO, Shao F.

Cell. 2019 Jul 25;178(3):552-566.e20. doi: 10.1016/j.cell.2019.06.007. Epub 2019 Jul 18.

PMID:
31327526
5.

Correction: SIRT2 regulates NF-κB-dependent gene expression through deacetylation of p65 Lys310 (doi:10.1242/jcs.073783).

Rothgiesser KM, Erener S, Waibel S, Lüscher B, Hottiger MO.

J Cell Sci. 2019 Apr 24;132(8). pii: jcs232801. doi: 10.1242/jcs.232801. No abstract available.

6.

A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation.

Higashi H, Maejima T, Lee LH, Yamazaki Y, Hottiger MO, Singh SA, Aikawa M.

J Proteome Res. 2019 Apr 5;18(4):1607-1622. doi: 10.1021/acs.jproteome.8b00895. Epub 2019 Mar 21.

7.

ARTD1 in Myeloid Cells Controls the IL-12/18-IFN-γ Axis in a Model of Sterile Sepsis, Chronic Bacterial Infection, and Cancer.

Kunze FA, Bauer M, Komuczki J, Lanzinger M, Gunasekera K, Hopp AK, Lehmann M, Becher B, Müller A, Hottiger MO.

J Immunol. 2019 Mar 1;202(5):1406-1416. doi: 10.4049/jimmunol.1801107. Epub 2019 Jan 23.

PMID:
30674576
8.

Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond.

Kunze FA, Hottiger MO.

Trends Immunol. 2019 Feb;40(2):159-173. doi: 10.1016/j.it.2018.12.006. Epub 2019 Jan 16. Review.

PMID:
30658897
9.

Validation of extracellular ligand-receptor interactions by Flow-TriCEPS.

Lopez-Garcia LA, Demiray L, Ruch-Marder S, Hopp AK, Hottiger MO, Helbling PM, Pavlou MP.

BMC Res Notes. 2018 Dec 5;11(1):863. doi: 10.1186/s13104-018-3974-5.

10.

Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells.

Tugues S, Amorim A, Spath S, Martin-Blondel G, Schreiner B, De Feo D, Lutz M, Guscetti F, Apostolova P, Haftmann C, Hasselblatt P, Núñez NG, Hottiger MO, van den Broek M, Manz MG, Zeiser R, Becher B.

Sci Transl Med. 2018 Nov 28;10(469). pii: eaat8410. doi: 10.1126/scitranslmed.aat8410.

PMID:
30487251
11.

Proteomic Characterization of the Heart and Skeletal Muscle Reveals Widespread Arginine ADP-Ribosylation by the ARTC1 Ectoenzyme.

Leutert M, Menzel S, Braren R, Rissiek B, Hopp AK, Nowak K, Bisceglie L, Gehrig P, Li H, Zolkiewska A, Koch-Nolte F, Hottiger MO.

Cell Rep. 2018 Aug 14;24(7):1916-1929.e5. doi: 10.1016/j.celrep.2018.07.048.

12.

Mono-ADP-Ribosylhydrolase Assays.

Abplanalp J, Hopp AK, Hottiger MO.

Methods Mol Biol. 2018;1813:205-213. doi: 10.1007/978-1-4939-8588-3_13.

PMID:
30097869
13.

Comprehensive ADP-ribosylome analysis identifies tyrosine as an ADP-ribose acceptor site.

Leslie Pedrioli DM, Leutert M, Bilan V, Nowak K, Gunasekera K, Ferrari E, Imhof R, Malmström L, Hottiger MO.

EMBO Rep. 2018 Aug;19(8). pii: e45310. doi: 10.15252/embr.201745310. Epub 2018 Jun 28.

14.

Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase.

Abplanalp J, Leutert M, Frugier E, Nowak K, Feurer R, Kato J, Kistemaker HVA, Filippov DV, Moss J, Caflisch A, Hottiger MO.

Nat Commun. 2017 Dec 12;8(1):2055. doi: 10.1038/s41467-017-02253-1.

15.

Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia.

Rissiek B, Menzel S, Leutert M, Cordes M, Behr S, Jank L, Ludewig P, Gelderblom M, Rissiek A, Adriouch S, Haag F, Hottiger MO, Koch-Nolte F, Magnus T.

Sci Rep. 2017 Nov 28;7(1):16477. doi: 10.1038/s41598-017-16613-w.

16.

ADP-ribose-specific chromatin-affinity purification for investigating genome-wide or locus-specific chromatin ADP-ribosylation.

Bisceglie L, Bartolomei G, Hottiger MO.

Nat Protoc. 2017 Sep;12(9):1951-1961. doi: 10.1038/nprot.2017.072. Epub 2017 Aug 24.

PMID:
28837130
17.

Proteome-Wide Identification of In Vivo ADP-Ribose Acceptor Sites by Liquid Chromatography-Tandem Mass Spectrometry.

Larsen SC, Leutert M, Bilan V, Martello R, Jungmichel S, Young C, Hottiger MO, Nielsen ML.

Methods Mol Biol. 2017;1608:149-162. doi: 10.1007/978-1-4939-6993-7_11.

PMID:
28695509
18.

Identification of ADP-Ribose Acceptor Sites on In Vitro Modified Proteins by Liquid Chromatography-Tandem Mass Spectrometry.

Leutert M, Bilan V, Gehrig P, Hottiger MO.

Methods Mol Biol. 2017;1608:137-148. doi: 10.1007/978-1-4939-6993-7_10.

PMID:
28695508
19.

New Quantitative Mass Spectrometry Approaches Reveal Different ADP-ribosylation Phases Dependent On the Levels of Oxidative Stress.

Bilan V, Selevsek N, Kistemaker HAV, Abplanalp J, Feurer R, Filippov DV, Hottiger MO.

Mol Cell Proteomics. 2017 May;16(5):949-958. doi: 10.1074/mcp.O116.065623. Epub 2017 Mar 21.

20.

Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage.

Buzzo CL, Medina T, Branco LM, Lage SL, Ferreira LC, Amarante-Mendes GP, Hottiger MO, De Carvalho DD, Bortoluci KR.

Sci Rep. 2017 Feb 2;7:41686. doi: 10.1038/srep41686.

Supplemental Content

Loading ...
Support Center